SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChurchill China Regulatory News (CHH)

Share Price Information for Churchill China (CHH)

Share Price is delayed by 15 minutes
Get Live Data
340.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 20.00 (6.061%)
Market Cap: £37.39m
CHH Live PriceLast checked at - London Stock Exchange

Intraday Churchill China Share Chart

Full Year Trading Update 2025

2 Feb 2026 07:00

RNS Number : 2693R
Churchill China PLC
02 February 2026
 

For immediate release

2 February 2026

 

 

CHURCHILL CHINA plc

("Churchill" or the "Company" or the "Group")

 

Full Year Trading Update 2025

 

Churchill China plc (AIM: CHH), the manufacturer of innovative performance ceramic products serving hospitality markets worldwide, provides an update on trading for the year ended 31 December 2025.

The Company is pleased to confirm that trading in the second half of the year met its expectations, with turnover for the year at circa £76m and profit before tax expected to be in line with market expectations*.

 

Trading in Europe during the second half was ahead of the prior year, with the region ending the year broadly in line with 2024. We are confident that the actions taken in sales and marketing in this region are having a positive impact. Whilst the Company maintained market leader status in the UK, end users were affected by adverse macro-economic factors during the year. However, the run-in to Christmas was encouraging, with pub groups investing ahead of the holiday period and the order pipeline at year end was ahead of the prior year.

 

The USA ended the year ahead of 2024 despite the devaluation of the dollar in the period. Performance of 'Rest of the World' was softer, as large projects, on which this segment relies, were delayed and pushed out into later periods.

 

Materials performed well despite reduced sector volumes, although the decision of a key UK customer to source their materials supply directly will influence revenue going forward. However mitigating actions are expected to limit the impact on profitability.

 

Cash at year end finished ahead of the Company's opening position at £10.8m.

 

*Company calculated analyst consensus profit before tax is £6.0m for 2025.

 

For further information, please contact:

 

Churchill China plc

Tel: 01782 577566

David O'Connor / James Roper / Michael Cunningham

Burson Buchanan

Tel: 020 7466 5000

Mark Court / Sophie Wills / Abigail Gilchrist

ChurchillChina@buchanan.uk.com

 

 

Investec (Nominated Adviser and Joint Broker)

Tel: 020 7597 5970

David Flin / Oliver Cardigan

 

Panmure Liberum (Joint Broker)

Edward Thomas / John More

Tel: 020 3100 2000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPURGPUPQGBG
Date   Source Headline
29th May 20265:35 pmRNSResults of AGM
29th May 20267:00 amRNSAGM Statement
20th May 20262:45 pmRNSGrant of Options under LTIP
30th Apr 20264:40 pmRNSPosting of Annual Report and Notice of AGM
20th Apr 20267:00 amRNSDirector dealing
17th Apr 20264:21 pmRNSDirector dealing – Late Notification
15th Apr 20264:13 pmRNSNotification of Major Holdings
13th Apr 20267:00 amRNSFinal Results
1st Apr 20267:00 amRNSNotification of Final Results
26th Mar 20262:08 pmRNSNotification of Major Holdings
24th Feb 20265:31 pmRNSNotification of Major Holdings
2nd Feb 20267:00 amRNSFull Year Trading Update 2025
23rd Oct 20252:48 pmRNSDirector Dealing
21st Oct 20251:10 pmRNSNotification of Major Holdings
3rd Sep 20257:00 amRNSInterim Results
11th Aug 20257:00 amRNSNotification of Interim Results
17th Jul 20255:33 pmRNSNotification of Major Holdings
17th Jul 20257:00 amRNSTrading Update
20th Jun 20253:39 pmRNSGrant of Options under LTIP
30th May 20251:02 pmRNSNotification of Major Holdings
29th May 20254:01 pmRNSResult of AGM
29th May 20257:00 amRNSAGM Statement
22nd May 20252:29 pmRNSNotification of Major Holdings
7th May 20254:20 pmRNSPosting of Annual Report and Notice of AGM
15th Apr 20252:22 pmRNSDividend Declaration
9th Apr 20257:00 amRNSFinal Results
26th Mar 20257:01 amRNSNotification of Final Results
26th Mar 20257:00 amRNSAppointment of Joint Broker
18th Mar 20253:19 pmRNSNotification of Major Holdings
12th Mar 20255:00 pmRNSNotification of Major Holdings
3rd Feb 20257:00 amRNSFull Year Trading Update
17th Jan 20255:50 pmRNSNotification of Major Holdings
5th Dec 20243:08 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTrading Update
17th Oct 20246:03 pmRNSDirector/PDMR Shareholding
14th Oct 20241:51 pmRNSNotification of Major Holdings
11th Oct 20243:13 pmRNSPDMR/Substantial Shareholding Dealing
5th Sep 20247:00 amRNSInterim Results
6th Aug 20244:21 pmRNSNotification of Major Holdings
24th Jul 20247:00 amRNSHalf Year Trading Update and Notice of Results
5th Jun 20242:35 pmRNSResult of AGM
5th Jun 20247:00 amRNSAGM Statement
24th May 20245:30 pmRNSGrant of Options under LTIP
10th May 20244:45 pmRNSNotification of Major Holdings
10th May 202410:30 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20245:57 pmRNSDirector Dealing
30th Apr 20245:53 pmRNSDirector Dealing
16th Apr 20249:46 amRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSFinal Results
27th Mar 20249:30 amRNSNotification of Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.